本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

150.09
-2.0550-1.35%
盤後150.090.00000.00%16:47 EDT
成交量:51.45萬
成交額:7,782.24萬
市值:89.82億
市盈率:-22.20
高:155.45
開:147.56
低:147.56
收:152.15
資料載入中...
2019/02/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]